Hemodialysis clearance of intravenously administered ribavirin. 1990

T H Kramer, and G G Gaar, and C G Ray, and L Minnich, and J G Copeland, and J D Connor
Department of Pharmacology, University of Arizona Health Sciences Center, Tucson 85724.

A patient with an implanted artificial heart, acute, anuric renal failure, and disseminated influenza virus type A infection received intravenous ribavirin. Drug elimination by hemodialysis was measured. Plasma dialysis clearance averaged 93.9 +/- 8.6 ml/min. The maximum amount of ribavirin removed from the body during one period of hemodialysis was 79.1 mg. Ribavirin is not removed in important quantities by hemodialysis.

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D005260 Female Females
D006354 Heart, Artificial A pumping mechanism that duplicates the output, rate, and blood pressure of the natural heart. It may replace the function of the entire heart or a portion of it, and may be an intracorporeal, extracorporeal, or paracorporeal heart. (Dorland, 28th ed) Artificial Heart,Artificial Hearts,Hearts, Artificial
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012254 Ribavirin A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses. Ribovirin,Tribavirin,ICN-1229,Rebetol,Ribamide,Ribamidil,Ribamidyl,Ribasphere,Vilona,Viramide,Virazide,Virazole,ICN 1229,ICN1229
D012263 Ribonucleosides Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)

Related Publications

T H Kramer, and G G Gaar, and C G Ray, and L Minnich, and J G Copeland, and J D Connor
May 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
T H Kramer, and G G Gaar, and C G Ray, and L Minnich, and J G Copeland, and J D Connor
January 1983, The Japanese journal of surgery,
T H Kramer, and G G Gaar, and C G Ray, and L Minnich, and J G Copeland, and J D Connor
January 2018, Toxicology reports,
T H Kramer, and G G Gaar, and C G Ray, and L Minnich, and J G Copeland, and J D Connor
January 1984, JPEN. Journal of parenteral and enteral nutrition,
T H Kramer, and G G Gaar, and C G Ray, and L Minnich, and J G Copeland, and J D Connor
March 2014, Nanotoxicology,
T H Kramer, and G G Gaar, and C G Ray, and L Minnich, and J G Copeland, and J D Connor
March 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
T H Kramer, and G G Gaar, and C G Ray, and L Minnich, and J G Copeland, and J D Connor
January 1977, Acta anaesthesiologica Scandinavica,
T H Kramer, and G G Gaar, and C G Ray, and L Minnich, and J G Copeland, and J D Connor
January 1987, Advances in experimental medicine and biology,
T H Kramer, and G G Gaar, and C G Ray, and L Minnich, and J G Copeland, and J D Connor
June 1989, Journal of pharmaceutical sciences,
T H Kramer, and G G Gaar, and C G Ray, and L Minnich, and J G Copeland, and J D Connor
February 2006, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!